The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...

A recent teardown of Apple's new-generation AirTag reveals that while the speaker is louder, it's also pretty easy to tamper ...

Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing ...

Breakthrough Phase 2 Trial Results Show Promise for Patients Ineligible for Standard Reperfusion TherapiesData Presented at International Stroke ConferenceData Show That LT3001 Delivers Meaningful ...

A new predictive framework reprograms T cells to sustain immune memory while preserving their ability to fight cancer and infections.

Among adults with acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack (TIA) with planned ...

Bayer Aktiengesellschaft (ETR:BAYN) highlighted results from its OCEANIC-STROKE phase III trial during an investor webinar held at ISC 2026 in New Orleans, outlining what company executives and ...

Mandiant has observed an increase in ShinyHunters-branded attacks using evolved vishing and credential harvesting.

Hackers are abusing a legitimate but long-revoked EnCase kernel driver in an EDR killer that can detect 59 security tools in ...

An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic ...

NTLA stock faces binary risk: success could unlock multi-billion dollar markets, while setbacks may erase hundreds of ...

Q, a Detroit institution since 1964, will close Sunday after 60+ years due to declining traffic and owner's illness.